Yes! Weekly: Burzynski: Cancer is Serious Business Part II

6/20/2013 Mark Burger published a review:
——————————————————————
http://www.yesweekly.com/triad/article-16162-burzynski-cancer-is-.html
——————————————————————
As could be expected, The Skeptics™
showed up
======================================
ANONYMOUS: “I’m afraid you’ve fallen for Dr Burzynski’s PR efforts here”
——————————————————————
LIE: The documentary film is by Eric Merola, NOT “Dr. Burzynski’s Public Relations”
======================================
ANONYMOUS: “In reality, Dr B is a quack and a charlatan of the worst order, and the movie is nothing more than a desperate attempt to try to sell his snake oil to the gullible”
——————————————————————
LIE: After reading through the comments, this sounds like the infamous lying Professor Robert J. (Bob) Blaskiewicz of University of Wisconsin, Eau Claire, “infamy”, who is a charlatan of the first order, and belabors his ignorance by referring to “snake oil”, which as far as I know, has never been approved for phase III clinical trials, unlike Dr. Burzynski’s antineoplastons A10 (Atengenal) and AS2-1 (Astugenal)
——————————————————————
Bob Blaskiewicz (Blatherskitewicz), Faux Skeptic Exposed!:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/06/07/bob-blaskiewicz-blatherskitewicz-faux-skeptic-exposed/
======================================
ANONYMOUS: “You have to ask why he’s never published any data showing that his treatment works”
——————————————————————
LIE: What people should ask is why does “Professor” @rjblaskiewicz and his other Skeptic pals continue posting idiotic statements like this on the Internet and social media (Twitter) ?
——————————————————————
Critiquing David H. Gorski, MD, PhD, FACS
http://www.sciencebasedmedicine.org/editorial-staff/david-h-gorski-md-phd-managing-editor/
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/08/21/critiquing-david-h-gorski-md-phd-facs-www-sciencebasedmedicine-orgeditorial-staffdavid-h-gorski-md-phd-managing-editor/
======================================
ANONYMOUS: “Well, if you believe everything the movie tells you, then perhaps you think it’s because of a huge global conspiracy that prevents him from publishing in any journal anywhere in the world”
——————————————————————
If you want to talk Jesse Ventura type “conspiracy theory”:

1. Why are The Skeptics™ like you too afraid to debate ?

2. Why did your “pal” David H. “Orac” Gorski, MD, PhD, FACS block me on his blog for questioning his infallibility ?

3. Why did Forbes delete my comments when I questioned The Skeptics™? regarding your “pal” Gorski’s “bud”, Peter A. Lipson, MD’s article ?

4. Why did The Skeptics™ Josephine Jones block me from her blog ?

5. Why did The Skeptics™ Adam Jacobs block me from his blog ?

6. Why did The Skeptics™ Guy Chapman block me from his blog ?

7. Why did The Skeptics™ Keir Liddle block me from his blog ?

8. Why do The Skeptics™ whine to Twitter in order to get Twitter to suspend the accounts of people who question them ?

9. Why did Wikipedia block me, using lame excuses ?

10. Why did reddit act like wiki’s little bitch and delete my posts and block my comments because this reddiot davidreiss666 whined like a little bitch ?
——————————————————————
overview for DidymusJudasThomas (reddit.com)

submitted 4 days ago by davidreiss666 to reportthespammers

1 comment
======================================
ANONYMOUS: “Even if you are sufficiently conspiracy minded to believe that’s true, then it still doesn’t explain why he hasn’t published his results on the clinicaltrials dot gov website, where most of his trials are recorded as either “ongoing”, “withdrawn”, or “unknown status””
——————————————————————
Did you NOT appear on the below blog talk radio show with your “pal” Gorski who said at 29:00 that Burzynski should NOT publish the information himself ?
——————————————————————
Ep09 – Talking Burzynski – David Gorski and Bob Blaskiewicz 05/29/2013
Skeptic Canary ShowBlogTalkRadio
May 29, 2013 … This week, join your hosts as we talk about Dr. Stanislaw Burzynski and the Burzynski Clinic. Well be joined by two special guest, Doctor David Gorski and Bob Blaskiewicz
http://www.blogtalkradio.com/…/ep09–talking-burzynski–david-gorski-and-bob-blaskiewicz
——————————————————————
http://www.blogtalkradio.com/skepticcanary/2013/05/29/ep09–talking-burzynski–david-gorski-and-bob-blaskiewicz
——————————————————————
http://goo.gl/7pWIj
——————————————————————
http://bit.ly/15lv5zG
——————————————————————
Critiquing the #SkepticCanary: “The Skeptics™” (SkeptiCowards©) Bob Blatherskitewicz and the so-called, “self-proclaimed” “CANCER RESEARCHER”:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/06/03/critiquing-the-skepticcanary-the-skeptics-skepticowards-bob-blatherskitewicz-and-the-so-called-self-proclaimed-cancer-researcher/
======================================
ANONYMOUS: “Only one of his trials is recorded as being completed, and that one doesn’t reveal it’s results”
——————————————————————
Did you notice that your above 5/29/2013 appearance was BEFORE this article was published 6/20/2013 ?
======================================
ANONYMOUS: “The fact is that Burzynski keeps is actual research data an extremely closely guarded secret”
——————————————————————
Like THIS ?
——————————————————————
Critiquing: Dr. David H. “Orac” Gorski, M.D., Ph.D, L.I.A.R.:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/08/07/critiquing-dr-david-h-orac-gorski-m-d-ph-d-l-i-a-r/
======================================
ANONYMOUS: “If is treatment were actually effective, do you seriously think he’d do that?”
——————————————————————
RATS!!!. Like this ?
——————————————————————
Burzynski: Oh, RATS!!!
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/07/26/the-lancet-oncology-peer-review-team-d-12-01519-fail-2/
======================================
ANONYMOUS: “Burzynski likes to cultivate his conspiracy theories because it helps his business of scamming vulnerable cancer patients”
——————————————————————
Is that like The Skeptics™ like to LIE to people ?
——————————————————————
Critiquing: In which the latest movie about Stanislaw Burzynski “cancer cure” is reviewed…with Insolence:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/07/18/critiquing-in-which-the-latest-movie-about-stanislaw-burzynski-cancer-cure-is-reviewed-with-insolence-2/
======================================
ANONYMOUS: “For Burzynski, at least, cancer is indeed serious business”
——————————————————————
And for you, it must be a joke, considering how you are too much of a coward to debate questions like these
——————————————————————
QUESTIONS the Critics and Cynics, “The Skeptics™” do NOT want to ANSWER:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/06/23/questions-the-critics-and-cynics-the-skeptics-do-not-want-to-answer/
======================================
JEFF: “it has been tested independently in other countries, as the film shows”
======================================
ANONYMOUS: “The Japanese study remains unpublished, Jeff, just like all the over 60 studies Burzynski has started”

“Even if it were published, it would need to be replicated”
——————————————————————
Really ? Why not try pointing out where these studies were replicated before the FDA allowed these drugs to be used ?
——————————————————————
Burzynski: Why has the FDA NOT granted Accelerated Approval for Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal) ?
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/07/28/burzynski-why-has-the-fda-not-granted-accelerated-approval-for-antineoplastons-a10-astengenal-and-as2-1-astugenal/
======================================
ANONYMOUS: “Merola manipulated by voice, face and even what I said in his movie and never asked for my comments”

“Sure, he misrepresented me to my new employers, but that doesn’t actually count as consulting me, now does it?”

“The “birthday surprise” in the movie was a fundraiser for a children’s cancer research hospital that raised over $15K, something I’m rather proud of, actually”
——————————————————————
Nice TRY with your LIE
——————————————————————
Critiquing Bob Blaskiewicz (#Burzynski Cancer is Serious Business, Part II):
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/03/26/critiquing-bob-blaskiewicz-burzynski-cancer-is-serious-business-part-ii/
======================================
ANONYMOUS: “I’d encourage you to look at the other side of the story at The OTHER Burzynski Patient Group”

“These are far more typical outcomes”
——————————————————————
Do you mean this one of a number of your blogs which I just critiqued ?
——————————————————————
Critiquing https://theotherburzynskipatientgroup.wordpress.com
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/08/24/critiquing-httpstheotherburzynskipatientgroup-wordpress-com/
======================================
ANONYMOUS: “You might also see what Merola got wrong/faked at the anp4all website”
——————————————————————
Oh, do NOT worry

I will critique this one also, and let people see what YOU got wrong
======================================
ADAM JACOBS: “Jeff, you say it has been “tested independently in other countries”, but how do you know?”

“Because the movie says so?”

“Well, it would, wouldn’t it?”

“Come back and tell me about these so-called “independent tests” when they’ve been published”

“Until then, there is no reliable evidence that they actually happened”
——————————————————————
Adam Jacobs also known as @DianthusMed also known as Dianthus Medical of London, why don’t YOU come back and tell me when YOU learn how to read ?
——————————————————————
Burzynski – The Antineoplaston Randomized Japan Phase II Clinical Trial Study:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/03/28/burzynski-the-antineoplaston-randomized-japan-phase-ii-clinical-trial-study/
======================================
TOMMIE TAYLOR: “The worst conspiracy in the world and the most profitable is the mainstream medical procedures of surgery, chemotherapy, and radiation”

“Chemo and radiation destroy the immune system to the point that the body cannot heal”

“It is a crime against humanity to allow only these therapies”
======================================
ADAM JACOBS: “You do know that Burzynski uses chemotherapy, don’t you?”

“Antineoplastons themselves are a form of chemotherapy, but actually most of Burzynski’s patients don’t get ANPs anyway: they just get conventional chemotherapy”
——————————————————————
Adam, have you blocked anyone else from your blog since you blocked me because you are a coward ?
——————————————————————
The Burzynski Skeptics:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/08/18/the-burzynski-skeptics/
======================================

The Burzynski Skeptics

======================================
The Skeptics who are too SkepticScared too debate Burzynski
======================================
David H. Gorski, M.D., Ph.D
Orac
@gorskon
@oracknows
@ScienceBasedMed
#sciencebasedmedicine
Wayne State University
Barbara Ann Karmanos Cancer Center / Institute
Detroit, Michigan
——————————————————————
http://www.scienceblogs.com/Insolence/
——————————————————————
http://www.sciencebasedmedicine.org/
——————————————————————
http://www.sciencebasedmedicine.org/editorial-staff/david-h-gorski-md-phd-managing-editor/
——————————————————————
http://www.med.wayne.edu/surgery/faculty/DGorski.html
——————————————————————
http://cancerbiologyprogram.med.wayne.edu/faculty/gorski.php
� � � � � � � � � � � � � � � � �
David James (@StortSkeptic) tweeted at 7:08pm – 1 Aug 13:

The new Doctor Who will be Stanislaw #Burzynski. He manages to continually avoid getting cornered and he gets away with murder.

David Gorski (@gorskon) tweeted at 11:02pm – 1 Aug 13:

@StortSkeptic Yes, but can #Burzynski time travel? https://twitter.com/gorskon/status/363147810620702721
� � � � � � � � � � � � � � � � �
======================================
Robert J. (Bob) Blaskiewicz, Professor
Bob Blaskiewicz Faux Skeptic Exposed!
@rjblatherskiewicz
Blatherskitewicz
University of Wisconsin
rbutr
r-but-r
Eau Claire, Wisconsin
——————————————————————
http://www.skepticalhumanities.com/
——————————————————————
http://virtualskeptics.com/
——————————————————————
http://rbutr.com/
——————————————————————
http://blog.rbutr.com/
——————————————————————
http://www.uwec.edu/Staff/blaskir/
——————————————————————
http://www.csicop.org/author/rblaskiewicz
——————————————————————
http://necss.org/speakers/bob-blaskiewicz/
——————————————————————
http://www.centerforinquiry.net/speakers/blaskiewicz_bob
——————————————————————
http://lanyrd.com/2013/tam/sckkdy/
======================================
http://thehoustoncancerquack.com/
——————————————————————
http://anp4all.com/
� � � � � � � � � � � � � � � � �
Bob Blaskiewicz (@rjblaskiewicz)
6/3/13, 3:49 PM

@FauxSkeptic @bbc5live I believe he said, “Put up or shut up, you little bitch.” Something like that.
� � � � � � � � � � � � � � � � �
David James
@StortSkeptic
#SkepticCanary
@skepticCanary
The Skeptic Canary
Skeptic Canary Show
——————————————————————
http://www.skeptical.gb.net/
——————————————————————
http://www.blogtalkradio.com/skepticcanary/
� � � � � � � � � � � � � � � � �
David James (@StortSkeptic) tweeted at 7:08pm – 1 Aug 13:

The new Doctor Who will be Stanislaw #Burzynski. He manages to continually avoid getting cornered and he gets away with murder.

� � � � � � � � � � � � � � � � �
======================================
Guy Chapman
guychapman
@SceptiGuy
@vGuyUK
United Kingdom
——————————————————————
http://www.chapmancentral.co.uk/blahg/
======================================
Adam Jacobs
@DianthusMed
Dianthus Medical
London, United Kingdom
——————————————————————
http://www.dianthus.co.uk/blog/
======================================
Peter Bowditch
@RatbagsDotCom
� � � � � � � � � � � � � � � � �
Peter Bowditch (@RatbagsDotCom) tweeted at 8:09pm – 19 Feb 13:

Of course it’s always possible that the money launderers are appearing as themselves in the #Burzynski advertisement.

� � � � � � � � � � � � � � � � �
Josephine Jones
@_JosephineJones
——————————————————————
http://josephinejones.wordpress.com/
======================================
Keir Liddle
@Endless_Psych
——————————————————————
http://www.thetwentyfirstfloor.com/
——————————————————————
http://the21stfloor.tumblr.com
——————————————————————
http://twentyfirstfloormirror.wordpress.com
——————————————————————
http://www.thetwentyfirstfloor.com/?p=8146/
======================================
Paul Morgan
@drpaulmorgan
Cardiff, Wales
——————————————————————
http://medicine.cf.ac.uk/person/prof-paul-morgan/
======================================
FW
@frozenwarning
National Health Service (NHS)
Britain
United Kingdom
——————————————————————
Skeptics enjoy commenting on things that they do not know if it’s true or not

FW (@frozenwarning) tweeted at 5:01am – 14 Mar 13:

If it’s true that #burzynski and his adman Merola have insinuated that parents are to blame for Amelia’s death that’s utterly disgusting.

======================================
Rhys Morgan
Wales
——————————————————————
http://rhysmorgan.co/blog
——————————————————————
http://thewelshboyo.wordpress.com
======================================
Boris Ogon
@BorisOgon
“You are right now having a live “debate” in front of more than 10,000 people, and nothing you have presented suggests that you would be more coherent in person
——————————————————————
The Poxes Blog
https://thepoxesblog.wordpress.com
======================================
MedTek
@medtek
======================================
Quidama
@IAmBreastCancer
======================================
lilady
======================================
Peter A. Lipson, M.D.
@palMD
——————————————————————
http://www.sciencebasedmedicine.org/editorial-staff/peter-a-lipson-md/
——————————————————————
onforb.es/11pwse9
——————————————————————
http://t.co/vh3cgAR6hW
——————————————————————
http://www.forbes.com/sites/peterlipson/2013/04/19/a-film-producer-a-cancer-doctor-and-their-critics
——————————————————————
http://www.forbes.com/sites/peterlipson/
� � � � � � � � � � � � � � � � �
PalMD (@palmd) tweeted at 9:12am – 20 Apr 13:

Didnt take long for the Burzynski trolls to show up. http://t.co/EHgW0hnLAc

� � � � � � � � � � � � � � � � �
Dan Buzzard (@DanBuzzard) tweeted at 10:18am – 31 Mar 12:

@BurzynskiSaves I don’t care what you think. My only concern is for the cancer patients. People like #burzynski make me sick.

Sheila Herron (@Ac2cSheila) tweeted at 1:54pm – 31 Mar 12:

� � � � � � � � � � � � � � � � �

August 15, 1935, A Day That Will Live In Infirmary

On that day, Oklahoman William Penn Adair “Will” Rogers departed from us, leaving America wondering who would be able to fill the shoes left by a man with the “gift of gab,” and full of such Wit and Wisdom?

Who would take his place ?

George Herbert Walker Bush:

“Read My Lips” “No New Taxes” ?

William (call me “Bill”) Jefferson Clinton:

“It Depends Upon What the Meaning of the Word “IS,” is” ?

George W. Bush:

The “Mission Accomplished” Speech ?

Barack Hussein Obama:

“Yes We Can” ?

And BEHOLD

The Magic 8-Ball appeared before HIM in a curling whisp of smoke, and HE stretched forth HIS hand, and spake to the “Oracolytes,” assembled before HIM thusly as a mighty milling herd of Sheeple

“Orac”

Supreme “Leader” of the “Oracolytes”

“Dr. David H. Gorski”
(@gorskon, @oracknows, @sciencebasedmed, #sciencebasedmedicine
http://www.scienceblogs.com/Insolence,
http://www.sciencebasedmedicine.org)
“Unlike Mr. Merola, I am indeed very concerned with getting my facts correct”
http://scienceblogs.com/insolence/2013/06/07/i-want-my-anp/
And the bleating that arose was tremendous in its force and power, deafening –

“the ignorant, the unthinking and the credulous.”‘

Many had to be immediately evacuated to the nearest infirmary to have their stitches removed, having been tied in stitches by laughter, yea, stitched to be tied

And so plods forward the “War on Cancer”

“Unlike Mr.Merola,I am…very concerned with getting my facts correct”
FIE
FeeFIE
FeeFIEFo
FeeFIEFoFUM
Dum,DumDumDUMB
http://redd.it/1dry25

WHAT IS MISDIRECTION? Critiquing “Antineoplastons: Has the FDA kept its promise to the American people ?”

March 29, 1996

Then United States Food and Drug Administration Commissioner, David Kessler told the American people:

1. We will eliminate unnecessary paperwork … that used to delay or discourage … cancer research … by non-commercial clinical investigators

2. The … FDA’s initiatives … will allow …the agency … to rely on smaller trialsfewer patients … if there is evidence … of partial response in clinical trials

I don’t want to get into any particular … agent … except let me point out … that … the information needs to be part … of clinical trials

3. We will accept … less informationup front

4. we’re going to require further study AFTERapproval … because the science … has matured

5. The important – point … is that information needs to be gathered … through scientific means … through clinical – trials … and I think – that’s … that’s very important uhh very … important point

You can’t … just … use an agent here – or there … you have to use it … as part of a clinical trial … so we can get information … on whether the drug works

6. The uhh agency has … many … trials … has has approved trials … for patients … with antineoplastons

7. We are committed to providing expanded access … availability … for American patients for any drug … there’s reason to believe … may work
——————————————————————
BOTTOM LINE:
——————————————————————
Everything else is MISDIRECTION
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/03/22/antineoplastons-has-the-fda-kept-its-promise-to-the-american-people
——————————————————————
A. What is the FDA’s definition of “unnecessary paperwork”?

B. What is the FDA’s definition of “smaller trials”?

C. What is the FDA’s definition of “fewer patients”?

D. What is the FDA’s definition of “evidence … of partial response“?

E. What is the FDA’s definition of “less information … up front”?

F. What is the FDA’s definition of “we’re going to require further study AFTER … approval”?

G. What is the FDA’s definition of “We are committed to providing expanded access … availability … for American patients for any drug … there’s reason to believe … may work”?
======================================
2003 – 2009 Phase II preliminary
——————————————————————
2003 – Phase II
http://www.ncbi.nlm.nih.gov/m/pubmed/12718563
Drugs R D. 2003;4(2):91-101
(Drugs in R and D / Drugs in Research and Development)

2003: Protocol – recurrent diffuse intrinsic brain stem glioma

12 – Patients Accrued
10 – Evaluable Patients

2 / 20% – # and % of Patients Showing Complete Response
3 / 30% – # and % of Patients Showing Partial Response
3 / 30% – # and % of Patients Showing Stable Disease
2 / 20% – # and % of Patients Showing Progressive Disease
======================================
http://www.burzynskiclinic.com/scientific-publications.html
Interim Reports on Clinial Trials:

1. 10/2003

NEURO-ONCOLOGY

Burzynski, S.R., Weaver, R.A., Bestak, M., Lewy, R.I., Janicki, T.J., Jurida, G.F., Paszkowiak, J.K., Szymkowski, B.G., Khan, M.I.

Phase II study of Antineoplastons A10 and AS2-1 (ANP) in children with recurrent and progressive MULTICENTRIC GLIOMA

A preliminary report
http://www.burzynskiclinic.com/images/stories/Publications/970.pdf
Neuro-Oncology. 2003; 5: 358
Volume 5 Issue 4 October 2003

10/2003 – Protocol – MULTICENTRIC GLIOMA

12 – Children Patients Accrued
10 – Evaluable Patients
(9 months-17 years / 9 – median age)

4 / 33% – # and % of Patients Showing Complete Response
2 / 25% – # and % of Patients Showing Partial Response
4 / 33% – # and % of Patients Showing Stable Disease
0 / 0% – # and % of Patients Showing Progressive Disease
1 / 9% – # and % of Patients Nonevaluable due to only 4 weeks of treatment / lack of follow-up scans
======================================
Interim Reports on Clinial Trials:

16. 2003

DRUGS IN R&D
Drugs in R and D
(Drugs in Research and Development)

BT-11
BRAIN STEM GLIOMA

Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic BRAIN STEM GLIOMA:

a preliminary report.
http://www.ncbi.nlm.nih.gov/pubmed/12718563
Burzynski, S.R., Lewy, R.I., Weaver, R.A., Axler, M.L., Janicki, T.J., Jurida, G.F., Paszkowiak, J.K., Szymkowski, B.G., Khan, M.I., Bestak, M.
http://www.ncbi.nlm.nih.gov/m/pubmed/12718563
Drugs R D. 2003;4(2):91-101
Drugs in R&D 2003;4:91-101
http://www.burzynskiclinic.com/images/stories/Publications/960.pdf

Pgs. 91-92 and 95

3/1996 – Protocol – recurrent diffuse intrinsic BRAIN STEM GLIOMA (3/1996 – 5/1999 enrolled / Pg. 94)

12 – Patients Accrued (6 males / 6 females)
(4-29 years / 10 – median age)
10 – Evaluable Patients

2 / 20% – # and % of Patients Showing Complete Response
3 / 30% – # and % of Patients Showing Partial Response
3 / 30% – # and % of Patients Showing Stable Disease
2 / 20% – # and % of Patients Showing Progressive Disease
======================================
2004 – Phase II
http://www.ncbi.nlm.nih.gov/m/pubmed/15563234
Drugs R D. 2004;5(6):315-26
(Drugs in R and D / Drugs in Research and Development)

2004: Protocol – incurable recurrent and progressive multicentric glioma

12 – Patients Accrued
(9 – median age)
11 – Evaluable Patients

4 / 33% – # and % of Patients Showing Complete Response
3 / 25% – # and % of Patients Showing Partial Response
4 / 33% – # and % of Patients Showing Stable Disease
0 / 0% – # and % of Patients Showing Progressive Disease
======================================
Interim Reports on Clinial Trials:

2. 10/2004

NEURO-ONCOLOGY

BT-20
Patients With GLIOBLASTOMA MULTIFORME (GBM)

Weaver, R.A., Burzynski, S.R., Bestak, M., Lewy, R.I., Janicki, T.J., Szymkowski, B., Jurida, G., Khan, M.I., Dolgopolov, V.

Phase II study of Antineoplastons A10 and AS2-1 (ANP) in recurrent GLIOBLASTOMA MULTIFORME
http://www.burzynskiclinic.com/images/stories/Publications/1218.pdf
Neuro-Oncology. 2004; 6: 384
Volume 6 Issue 4 October 2004
Abstracts from the Society for Neuro-Oncology Ninth Annual Meeting, Toronto, Ontario, Canada, November 18-21, 2004

Pg. 385

10/2004 – Protocol – glioblastoma multiforme (GBM) which recurred or progressed post surgery, radiation therapy, and / or chemotherapy

22 – Evaluable Patients
(6 men / 16 women / 27-63 /47 – median age)

1 / 4.5% – # and % of Patients Showing Complete Response
1 / 4.5% – # and % of Patients Showing Partial Response
12 / 54.5% – # and % of Patients Showing Stable Disease
8 / 36.5% – # and % of Patients Showing Progressive Disease
======================================
Interim Reports on Clinial Trials:

3. 10/2004 (DBSG)

NEURO-ONCOLOGY

Burzynski, S.R., Weaver, R. Bestak. M., Lewy, R.I., Janicki, T., Jurida, G., Szymkowski, B., Khan, M., Dolgopolov, V.

Long-term survivals in phase II studies of Antineoplastons A10 and AS2-1 (ANP) in patients with diffuse intrinsic BRAIN STEM GLIOMA
http://www.burzynskiclinic.com/images/stories/Publications/1219.pdf
Neuro-Oncology. 2004; 6: 386
Volume 6 Issue 4 October 2004

60 patients
(31 didn’t meet admission criteria to the study and were treated under Special Exception (SE))

10/2004 – Protocol – patients with diffuse intrinsic BRAIN STEM GLIOMA (DBSG)

29 – Evaluable Patients

7 / 24% – # and % of Patients Showing Complete Response
6 / 21% – # and % of Patients Showing Partial Response
6 / 21% – # and % of Patients Showing Stable Disease
10 / 34% – # and % of Patients Showing Progressive Disease
——————————————————————
31 – Evaluable Patients: Special exception (SE)

5 / 16% – # and % of Patients Showing Complete Response
2 / 6% – # and % of Patients Showing Partial Response
16 / 52% – # and % of Patients Showing Stable Disease
8 / 26% – # and % of Patients Showing Progressive Disease
======================================
Interim Reports on Clinial Trials:

4. 10/2004 (AT/RT of CNS)

NEURO-ONCOLOGY

BT-14

CHILDREN WITH RHABDOID TUMOR OF THE CENTRAL NERVOUS SYSTEM

Burzynski, S.R., Weaver, R. Bestak. M., Janicki, T., Jurida, G., Szymkowski, B., Khan, M., Dolgopolov, V.

Phase II studies of antineoplastons A10 and AS2-1 (ANP) in children with atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system

A preliminary report
http://www.burzynskiclinic.com/images/stories/Publications/1146.pdf
Neuro-Oncology. 2004; 6: 427
Volume 6 Issue 4 October 2004
Abstracts from the Eleventh International Symposium on Pediatric Neuro-Oncology, Boston, Massachusetts, June 13-16, 2004

10/2004 – Protocol – children with atypical teratoid / rhabdoid tumors (AT / RT) of the central nervous system

11 – Children Patients Accrued
8 – Evaluable Patients
(7 treated under Special Exception (SE))

2 / 25% – # and % of Patients Showing Complete Response
1 / 12.5% – # and % of Patients Showing Partial Response
1 / 12.5% – # and % of Patients Showing Stable Disease
4 / 50% – # and % of Patients Showing Progressive Disease
======================================
Interim Reports on Clinial Trials:

5. 10/2004

NEURO-ONCOLOGY

BT-12

CHILDREN WITH PRIMITIVE NEUROECTODERMAL TUMORS (PNET)

Burzynski, S.R., Weaver, R. Bestak. M., Janicki, T., Szymkowski, B., Jurida, G., Khan, M., Dolgopolov, V.

Treatment of PRIMITIVE NEUROECTODERMAL TUMORS (PNET) with antineoplastons A10 and AS2-1 (ANP)

Preliminary results of phase II studies
http://www.burzynskiclinic.com/images/stories/Publications/1147.pdf
Neuro-Oncology. 2004; 6: 428
Volume 6 Issue 4 October 2004
Abstracts from the Eleventh International Symposium on Pediatric Neuro-Oncology

10/2004 – Protocol – PRIMITIVE NEUROECTODERMAL TUMORS (PNET)

17 – Patients Accrued
15 – Evaluable Patients
(12 months – 23 years / 6 – median age)

3 / 20% – # and % of Patients Showing Complete Response
2 / 13.4% – # and % of Patients Showing Partial Response
5 / 33.3% – # and % of Patients Showing Stable Disease
5 / 33.3% – # and % of Patients Showing Progressive Disease
======================================
Interim Reports on Clinial Trials:

17. 2004

DRUGS IN R&D
Drugs in R and D
(Drugs in Research and Development)

Burzynski, S.R., Weaver, R., Lewy, R., Janicki, T. Jurida, G., Szymkowski, B., Khan, M., Bestak, M.

Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma.

A Preliminary Report.
http://www.ncbi.nlm.nih.gov/pubmed/15563234
Drugs R&D 2004;5(6):315-326.
http://www.ncbi.nlm.nih.gov/m/pubmed/15563234
Drugs R D. 2004;5(6):315-26
http://www.burzynskiclinic.com/images/stories/Publications/1194.pdf

incurable recurrent and progressive multicentric glioma

Pg. 320

3 – treated under Special Exception (SE) granted by the US FDA

Pgs. 317 and 320

7/31/1996 – (7/31/1996 – 4/3/2002 as of 3/1/2004) Protocol – children with recurrent and progressive multicentric glioma (MCG)

Pg. 317

BT-13

children with low-grade astrocytoma

BT-23

children with visual pathway gliomas


Pgs. 317 and 320-321

12 – Children Patients Accrued (Pgs. 315-316)
(9 months – 17 years / 9- median age)
(6 – male / 6 – females)
10 – Evaluable Patients (Pg. 315)

4 / 33% – # and % of Patients Showing Complete Response
3 / 25% – # and % of Patients Showing Partial Response
4 / 33% – # and % of Patients Showing Stable Disease
0 / 0% – # and % of Patients Showing Progressive Disease
1 / 9% – # and % of Patients Non-evaluable
——————————————————————
Pg. 325

Compare: Chamberlain and Grafe. [38]

1995 – Protocol – solitary recurrent chiasmatic hypothalamic gliomas treated with oral etoposide


14 – Patients Accrued
14 – Evaluable Patients

1 / 7% – # and % of Patients Showing Complete Response
4 / 29% – # and % of Patients Showing Partial Response
3 / 21% – # and % of Patients Showing Stable Disease
6 / 43% – # and % of Patients Showing Progressive Disease

Pg. 326

38. Chamberlain MC, Grafe MR. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol 1995; 13: 2072-6
http://www.ncbi.nlm.nih.gov/pubmed/7636550/
J Clin Oncol. 1995 Aug;13(8):2072-6.
http://www.ncbi.nlm.nih.gov/m/pubmed/7636550/
Department of Neurosciences, University of California, San Diego, La Jolla, USA.
http://m.jco.ascopubs.org/content/13/8/2072.long
Arch Neurol. 1995 May;52(5):509-13.
http://www.ncbi.nlm.nih.gov/pubmed/7733847/
Department of Neurosciences, University of California-San Diego, USA.
http://www.ncbi.nlm.nih.gov/m/pubmed/7733847/
Arch Neurol. 1995;52(5):509-513. doi:10.1001/archneur.1995.00540290099024.
http://archneur.jamanetwork.com/Mobile/article.aspx?articleid=593460
——————————————————————
Compare: The Pediatric Oncology Group. [39]

10/2000 – Protocol – solitary progressive optic pathway tumors with carboplatin

50 – Patients Accrued
50 – Evaluable Patients

2 / 4% – # and % of Patients Showing Partial Response
37 / 74% – # and % of Patients Showing Stable Disease
11 / 22% – # and % of Patients Showing Progressive Disease

39. Mahoney DH, Cohen ME, Friedman HS, et al. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro-oncol 2000; 2: 213-20
http://www.ncbi.nlm.nih.gov/pubmed/11265230/
Neuro Oncol. 2000 Oct;2(4):213-20.
http://www.ncbi.nlm.nih.gov/m/pubmed/11265230/
Baylor College of Medicine, Houston, TX, USA.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920597/

http://neuro-oncology.oxfordjournals.org/content/2/4/213.full.pdf
======================================
2005 – Phase II
http://www.ncbi.nlm.nih.gov/m/pubmed/15911929
Integr Cancer Ther. 2005 Jun;4(2):168-77
(Integrative Cancer Therapies)

2005: Protocol – recurrent disease or high risk

13 – Patients Accrued
(1-11 – age / 5 years 11 months – median age)
13 – Evaluable Patients

3 / 23% – # and % of Patients Showing Complete Response
1 / 8% – # and % of Patients Showing Partial Response
4 / 31% – # and % of Patients Showing Stable Disease
5 / 38% – # and % of Patients Showing Progressive Disease
——————————————————————
(Updated 2007)
http://www.cancer-therapy.org/CT/v5/B/HTML/42._Burzynski,_379-390.html
2005 – Protocol – incurable recurrent and progressive multicentric glioma

13 – Patients Accrued

3 / 23% – # and % of Patients Showing Complete Response
1 / 8% – # and % of Patients Showing Partial Response
4 / 31% – # and % of Patients Showing Stable Disease
5 / 38% – # and % of Patients Showing Progressive Disease
======================================
2006 – Phase II
http://www.ncbi.nlm.nih.gov/m/pubmed/16484713
Integr Cancer Ther. 2006 Mar;5(1):40-7
(Integrative Cancer Therapies)

2006: Protocol – high-grade pathology (HBSG)

– Patients Accrued
18 – Evaluable Patients

2 / 11% – # and % of Patients Showing Complete Response
2 / 11% – # and % of Patients Showing Partial Response
7 / 39% – # and % of Patients Showing Stable Disease
7 / 39% – # and % of Patients Showing Progressive Disease
======================================
Interim Reports on Clinial Trials:

BT-03


BT-11

BRAIN STEM GLIOMA (BSG)

BT-18

6. MIXED GLIOMA

ADULT PATIENTS WITH MIXED GLIOMA

“mixed glioma”, a type of primary malignant brain tumor (PMBT)

BT-22

8. CHILDREN WITH PRIMARY MALIGNANT BRAIN TUMORS

CAN-01 (CAN-1)

PATIENTS WITH REFRACTORY MALIGNANCIES

19. 3/2006

Burzynski, S.R., Janicki, T.J., Weaver, R.A., Burzynski, B. Targeted therapy with Antineoplastons A10 and AS2-1 of high grade, recurrent, and progressive BRAINSTEM GLIOMA. Integrative Cancer Therapies 2006;5(1):40-47
http://www.ncbi.nlm.nih.gov/pubmed/16484713
Integr Cancer Ther. 2006 Mar;5(1):40-7
http://www.ncbi.nlm.nih.gov/m/pubmed/16484713
DOI: 10.1177/1534735405285380
http://www.burzynskiclinic.com/images/stories/Publications/5825.pdf

http://m.ict.sagepub.com/content/5/1/40.long?view=long&pmid=16484713
Pgs. 40-41

4 phase 2 trials

BRAINSTEM GLIOMA (BSG)

patients with inoperable tumor of high-grade pathology (HBSG)
glioblastoma

recurrent diffuse intrinsic glioblastomas and ANAPLASTIC ASTROCYTOMAs of brainstem

Pg. 43

BT-03 – 1 / female
BT-11 – 13 (8 males/5 females)
BT-18 – 1 / female
BT-22 – 2 / females
CAN-01 – 1 / female

Pg. 44

High-grade, recurrent, and progressive brainstem gliomas

Pgs. 40-42 and 44-45

7/12/1988 (7/12/1988 – 11/13/2003 as of 6/10/2005) – Protocol – recurrent diffuse intrinsic glioblastomas and anaplastic astrocytomas of the brainstem high-grade pathology (HBSG)

18 – Evaluable Patients (Pgs. 40-43)
(8 males / 10 females / 2-42 / 10 – median age / Pgs. 42-43)

2 / 11% – # and % of Patients Showing Complete Response
2 / 11% – # and % of Patients Showing Partial Response
7 / 39% – # and % of Patients Showing Stable Disease
7 / 39% – # and % of Patients Showing Progressive Disease
======================================
Interim Reports on Clinial Trials:

BT-11

BRAIN STEM GLIOMA

8. 10/2006

Burzynski, S.R., Janicki, T.J., Weaver, R.A., Szymkowski, B.G., Khan, M.I., Dolgopolov, V. Treatment of multicentric BRAINSTEM GLIOMAs with antineoplastons (ANP) A10 and AS2-1. Neuro-Oncology. 2006; 8:466.
http://www.burzynskiclinic.com/images/stories/Publications/2105.pdf
Volume 8 Issue 4 October 2006
Abstracts for the Eleventh Annual Meeting of the Society for Neuro-Oncology (SNO)

Brainstem gliomas and multicentric tumors (MBSG)

10/2006 – Protocol – Brainstem gliomas and multicentric tumors (MBSG)

19 – Evaluable Patients
3.9 – 40.8 years (9.2 – median age)
(90% less than 18 years old)

2 / 11% – # and % of Patients Showing Complete Response
1 / 5% – # and % of Patients Showing Partial Response
7 / 37% – # and % of Patients Showing Stable Disease
9 / 47% – # and % of Patients Showing Progressive Disease
======================================
2007
http://www.burzynskiclinic.com/images/stories/Publications/1252.pdf
2004 – Protocol – small group of patients with progressive LGA, ANP
60% – % of Patients Showing Complete Response
10% – % of Patients Showing Partial Response
——————————————————————
2004 – Protocol – low-grade astrocytoma in children
Burzynski [39] – Reference
Phase II d – d = Preliminary results – Study type
P – P = progressive tumor – Tumor type
(no. of pts) – pts = patients
ANP (10) – ANP = antineoplastons A10 and AS2-1 – Treatment
10 – Evaluable Patients {(78) = most in a study}
OS [%] – OS = overall survival
100% (1 yr) – 90% (3 yr) – Efficacy
93 mo – MST = MST = median survival time – {96 (1 y) next closest}
60% (6) – % and # of Patients Showing Complete Response {24 (11) next closest}
10% (1) – % and # of Patients Showing Partial Response {60% (9) best other study}
30% (3) – % and # of Patients Showing Stable Disease + MR = minor response {70% (14) best other study}
0% (0) – % and # of Patients Showing Progressive Disease {4% (2) next closest}
PFS (%)
90 (1 y) – 90 (3 y) – PFS = progression-free survival {100 (1 y) – 68 (3 y) best other study
——————————————————————
2004 – Protocol – diffuse, intrinsic brainstem glioma in children
Burzynski et al. [88] – Reference
Phase II – Study Type
(no. of pts) – pts = patients
RP (30) – RP = recurrent and progressive tumor – Tumor type
30 – Evaluable Patients
ANP – ANP = antineoplastons A10 and AS2-1 – Treatment – ANP
OS (%) – OS = overall survival
[2y; 5y]
46.7; 30 – Efficacy
MST (mo)
19.9 – MST = median survival time
27% (8) – % and # of Patients Showing Complete Response
20% (6) – % and # of Patients Showing Partial Response
23% (7) – % and # of Patients Showing Stable Disease
30% (9) – % and # of Patients Showing Progressive Disease
——————————————————————
Burzynski et al. [89] – Reference
Phase II – Study Type
(no. of pts) – pts = patients
RPS (10) – RPS = recurrent and progressive tumors in children aged <4y – Tumor type {(66) = most in a study}
ANP – ANP = antineoplastons A10 and AS2-1 – Treatment – ANP
OS (%) – OS = overall survival
[2y; 5y] – Efficacy
60; 20 {46.7 (30) = next best study}
MST (mo)
26.3 – MST = median survival time – {19.9 = next best study}
[% (no. )]
30% (3) – CR = complete response – {27% (8) = next best study}
[% (no. )]
0% (0) – PR = partial response – {56% (1) = next best}
[% (no. )]
40% (4) – SD = stable disease – {44% (25) = best}
[% (no. )]
30% (3) – PD = progressive disease – {23% (13) = best}
� � � � � � � � � � � � � � � � �
Interim Reports on Clinial Trials:

BT-11

BRAIN STEM GLIOMA

9. 4/2007 (NDBSG)

Burzynski, S.R., Weaver, R.A., Janicki, T.J., Jurida, G.F., Szymkowski, B.G., Kubove, E. Phase II studies of Antineoplastons A10 and AS 2-1 (ANP) in children with newly diagnosed diffuse, intrinsic BRAINSTEM GLIOMAs. Neuro-Oncology 2007; 9:206.
http://www.burzynskiclinic.com/images/stories/Publications/4021.pdf
Volume 9 Issue 2 April 2007
Abstracts from the Twelfth International Symposium on Pediatric Neuro-Oncology

4/2007 – Protocol – newly diagnosed diffuse, intrinsic BRAINSTEM GLIOMAs (NDBSG)

20 – Evaluable assessable children Patients
(3 months-20 years – age)

6 / 30% – # and % of Patients Showing Complete Response
2 / 10% – # and % of Patients Showing Partial Response
4 / 20% – # and % of Patients Showing Stable Disease
8 / 40% – # and % of Patients Showing Progressive Disease
� � � � � � � � � � � � � � � � �
Interim Reports on Clinial Trials:

BT-11

BRAIN STEM GLIOMA

Special exception (SE)

13. 12/2009 (DBSG)

Burzynski, S.R., Janicki, T.J., Weaver, R.A., Szymkowski, B., Burzynski, G.S. Phase II study of antineoplastons A10 and AS2-1 in patients with BRAINSTEM GLIOMA. Protocol BC-BT-11. Neuro-Oncology 2009, 11:951.
http://www.burzynskiclinic.com/images/stories/Publications/8639.pdf
Volume 11 Issue 6 December 2009
Abstracts from the Third Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) and the Sixth Meeting of the Asian Society for Neuro-Oncology (ASNO)
May 11-14, 2009
Yokohama, Japan

12/2009 – Protocol – BRAINSTEM GLIOMAs

40 – Patients Accrued
28 – Evaluable Patients
(23 children / 5 young adults)

5 / 18% – # and % of Patients Showing Complete Response
4 / 14% – # and % of Patients Showing Partial Response
12 / 43% – # and % of Patients Showing Stable Disease
7 / 25% – # and % of Patients Showing Progressive Disease
——————————————————————
Special exception (SE)

12/2009 – Protocol – BRAINSTEM GLIOMAs

52 – Evaluable Patients
(40 children / 12 young adults)

5 / 10% – # and % of Patients Showing Complete Response
2 / 4% – # and % of Patients Showing Partial Response
28 / 54% – # and % of Patients Showing Stable Disease
17 / 32% – # and % of Patients Showing Progressive Disease
——————————————————————
BT-11 and special exception (SE)
92% – diffuse intrinsic brainstem gliomas (DBSG)

Overall survival (OS) – 2 years:
42% – special exception (SE)
36% – BT-11

Overall survival (OS) – 5 years:
19% – special exception (SE)
25% – BT-11
======================================
Compare: standard radiation therapy in combination with chemotherapy (RAT) (Mandell et al. 1999)

2% – % of Patients Showing Complete Response
31% – % of Patients Showing Partial Response

Mandell LR, Kadota R, Freeman C, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brain stem tumors: results of pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;43:959-964.
http://www.ncbi.nlm.nih.gov/pubmed/10192340/
Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):959-64.
http://www.ncbi.nlm.nih.gov/m/pubmed/10192340/
International Journal of Radiation Oncology*Biology*Physics
Volume 43, Issue 5, 15 March 1999, Pages 959–964
http://www.sciencedirect.com/science/article/pii/S036030169800501X
Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY, USA.
6/1992 – 10/1997

Overall survival (OS):
7% – 2 years
0% – 5 years
=====================================
COMBINED:
——————————————————————
Overall survival (OS) – 2 years:
——————————————————————
42% – antineoplastons: special exception (SE)

36% – antineoplastons: BT-11

7% – standard radiation therapy in combination with chemotherapy (RAT)
——————————————————————
Overall survival (OS) – 5 years:
——————————————————————
25% – antineoplastons: BT-11

19% – antineoplastons: special exception (SE)

0% – standard radiation therapy in combination with chemotherapy (RAT)
� � � � � � � � � � � � � � � � �
Break The Walls Down:

——————————————————————
And “THAT’s The BOTTOM LINE”
Because Stone Cold Said So

——————————————————————
IT’s GO TIME
Time To Play The Game:

——————————————————————
Break The Walls Down:

=====================================

The #Burzynski (B.S.) Bump Rap

Yo …

Let me tell you how it’s DONE

We don’t get paid to do IT

We just do it for FUN

We fact-check your SH*T

Until the morning SUN

We know we have you on the RUN

‘Cause you hide behind your keypad SON

We know your “C”-RAP

Because it came out from between your BUNS

And we “Smell What You’re COOKIN’”

And out it COMES

The same ol’ cr*p that rolls right off the tip of your TONGUE

Do you really believe your own HYPERBULL?

Or are you really that DUMB?

I KNOW, who I AM

I AM, Number ONE

I KNOW, who I AM

I don’t fit into your “Master Plan”

(Piss-Off)

I KNOW, who I AM

I AM Number ONE

I KNOW, who I AM

I AM, Number ONE

wiki-wiki-wiki

That’s right WIKIPEDIA

You’re NOT Number ONE

(I got HIS Number)

You threw your MUD

Then hid behind a Black-Hole SUN

You dished out your MUD-BATH

Did you think you had WON?

A Yellow-Journalism AWARD?

(THAT’s just Piss-Poor)

WikipedBiaS!

Did you say WikipediAin’t your SON?

Holy “C”-RAP!!

Did You See THAT!!!

All dressed up wearing your best CummerBUND

Did you think you could get away with thumbin’ your Nose at your own THUMB?

Dum, Dum Dum DUMB

Well here I COME

Like a little TRICKER-TREATER

Get outta here with your SCHTICK!!!

Oh NO, Here comes PETER

Yo, What’s THAT in his HAND?

I don’t think it’s a water METER

Maybe he caught another BOTTOM FEEDER!!!

Yo Yo Ma, I heard it was just another TWITTER TWEETER

Yo, Yo, Yo, YOU want “NEW” INSOLENCE?

I don’t need your “Cult” of “MUD”

“M”isinformation

“U”ndereducated

“D”isinformation

MIS-DIS-INFORMATION

Doctor DISSIMULATION

You’re the Metastasis of Misinformation

The scourge of a NATION

I heard you liked “HUSTLER”

Which explains your problem with Mental Master-Debation

Mel Brooks just called and said “HELLO BALLS”

But I heard your head was on VACATION

“You can’t handle the TRUTH”

If we got you on #MizTV

It’d be like: “really?, Really??, REALLY???”

YO

“You Can’t “C” Me”

You couldn’t handle an Epic Rap Battle of HIS-STORY

You’ve got delusions of “C”-Rappin’ with #Eminem on #MTV

Your #TedNugents #Nugents would be on display for the Whole World Wide Web to SEE

Maybe you should hurry up and run back home to your M-O-M-M-IEEE!!!

I KNOW, who I AM

I AM, Number ONE

I don’t fit into your “Master Plan”

I AM, Number ONE

(It’s better to be Pissed-OFF than Pissed-ON “little man”)

I KNOW, who I AM

I AM, Number ONE

Hey Ho “SkeptiCowards©”

Is THAT all you’ve GOT?

You remind me of Ike TURNER

Was THAT your best SHOT?

Maybe ya betta stay at HOME

Sittin’ on the POT

Until you solve that PROBLEM

That requires too much THOUGHT

Like how to answer a QUESTION

Or “Where are your FACTS?”

Because you’ve been runnin’, hidin’, and DODGIN”

After you had another Faux Tu-Quoque ATTACK

All I hear from some of youse MOUTHS

Is Quack-ack-ack-ack-ACK

I thought Billy Joel warned YOU

Bout having a Heart Attack-ack-ack-ack-ACK

This is the “Home of the BRAVE”

(Maybe you should “Learn to SWIM”)

Before you start to Hack-ack-ack-ack-ACK

George Washington cut down a Cherry TREE

(Was THAT your Cherry-Pickin’ Tree? Whoa is ME!)

They say Lizzie Borden gave her mother 40 Whack-ack-ack-ack-ACKS

• I KNOW, who I AM

I AM, Number ONE

I don’t fit into your “Master Plan” ?

I AM, who I AM

I KNOW, who I AM

I AM, Number ONE

I KNOW who I AM

I AM Number ONE

Oh NO! Here comes Peter AGAIN – FLEA!!

Did he really rob himself to pay PAUL?

I heard him mumble something ’bout CaliCultication

And another Brick in the WALL

Mary told me he denied himself THRICE

As he was trying to Break Down The WALLS

If we don’t hurry up we’ll be LATE

For the World Premiere of the New MONSTER’s BALLS

Lil’ Johnny’s got a DATE

With the New Kids Down the HALL

And we’re going to the “Stones'” CONCERT

We’re gonna throw some BACK

So ya betta’ duck YA’LL

Here’s comes some more Roberta FLACK

Now that wall doesn’t seem so TALL

They’re comin’ to America’s CALL

Now, why is #CMPunk a #Heyman Guy PAUL?

• I KNOW, who I AM

I AM, Number ONE

Your “Master Plan” is like a yellowed Bed Pan

I AM, who I AM

I KNOW, who I AM

I AM, Number ONE

I KNOW who I AM

I AM Number ONE

Oh NO !

Anyone heard ’bout what happens when Birds ATTACK?

Look Out BELOW!

The sky changes from 50 shades of Grey

To #Metallica #FadeToBLACK

Rockapocalypse !!!

@TheRock said #ItDoesntMatter

What BBC Spam-o-rama

the “Riddler” wannabe

or Blatherskitewicz SAID

Your #DavidBowie 15 seconds of #Fame

has you #BurningDownTheHouse with your #TalkingHEADS

#Jabroni

Critics and Cynics

“The Skeptics™”

I thought you had Grapefruits

like @VinceMcMahon

But all you’ve got is #FruityPebbles

like @JohnCena

I feel so ROBbed Van DAMN !!!

what ! What !! WHAT !!!

is your GOAL?

You wouldn’t touch”IT”with a #ZZTop #TenFootPOLE

Your #Garbage smells #Special

#NineInchNails #HeadLikeAHole ?

Your Salem Witch Trial

#HistoryOfTheWorld PartI

was FROZEN

BORING

#PinkFloyd #ComfortablyNUMB

Like a #SuperTramp

You #HideInYourShell

You Blatherskite without a CLUE

Who the … are YOU ?

#WhoAreYou ?

#TheWHO ?

#WeKnowThatTheHypnotizedNeverLie
http://youtu.be/zYMD_W_r3Fg #BloodyWellRight you SEE ?
http://t.co/IY53fEpnBu
You talk about “deconstruction”

#AWESOME

@TripleH #TimeToPlayTheGame ?

#MMA ?

#UFC ?

#WWE ?

Like #KidRock sings

“And this is for the Questions that don’t have any Answers”

U can’t out “C”-Rap ME

Yo #Eminem

May I Have Your Attention PLEASE ?

This ain’t about ME

It’s about the F-D-A
redd.it/1h2slh
and Dr. Stanislaw Rajmund #BURZYNSKI

• I KNOW, who I AM

I AM, Number ONE

I KNOW, who I AM

I AM, who I AM

I KNOW, who I AM

I AM, Number ONE

I KNOW who I AM

I AM Number ONE